Close Menu

Grants

Additional funding opportunities

Research Funding Opportunities

Tools to Find Funding

Grants Awarded for Health Sciences Research

Title Type $ Amount Activity Investigatorsort descending Unit Sponsor Date
IPA Agreement for Dr. Ashwani Gupta Contract $75,884.00 Research Ashwani Gupta Surgery United States Department of Veterans Affairs 07/2020
Anti-CV2 Autoantibodies Unmask a CRMP5/GluN2B Pain Signaling Hub Grant $1,794,930.00 Research Aubin Moutal Pharmacology National Institute of Neurological Disorders and Stroke 01/2021
3/7 Psychiatric Genomics Consortium: Advancing Discovery and Impact Grant $159,424.00 Research Ayman Fanous COM Phx Psychiatry Icahn School of Medicine at Mount Sinai 03/2022
A Pivotal Randomized, Open-label Study of Optune (TTFIELDS, 200khz) Concomitant With Radiation Therapy and Temozolomide for the Treatment of Newly Diagnosed Glioblastoma Contract $450,303.24 Clinical Trial Baldassarre Stea Cancer Center Division Novocure GmbH (SWITZERLAND) 06/2022
Member Institution Purchased Service Agreement with NRG Oncology Foundation for Institution's participation in the conduct of certain oncology clinical trials (the "NRG Agreement") Contract $215,025.00 Clinical Trial Baldassarre Stea Cancer Center Division NRG Oncology 03/2022
Evaluation of Patient Outcomes from KidneyCare on Renal Allografts Registry (OKRA) Contract $188,179.00 Clinical Trial Bekir Tanriover Medicine CareDx, Inc. 02/2021
A Randomized Clinical Trial of Andexanet Alfa in Acute Intracranial Hemorrhage in Patients Receiving an Oral Factor Xa Inhibitor Contract $535,294.50 Clinical Trial Bellal Joseph Surgery Portola Pharmaceuticals, Inc. 03/2021
A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic Strategies in Hospitals Adults with COVID-19 Contract $178,900.00 Clinical Trial Bellal Joseph Surgery New York University 04/2021
A Multicenter, Double-Blind, Multidose, Placebo-Controlled, Randomized, Parallel-Group, Phase 2 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 for Patients with Brain Contusion Contract $96,267.00 Clinical Trial Bellal Joseph Surgery Biogen Incorporated 03/2020
A Prospective, Randomized, Open-Label, Comparative Study to Assess the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) and Best Available Therapy for the Treatment of Serious... Contract $240,575.50 Clinical Trial Bellal Joseph Surgery Parexel International Corporation 03/2020
Non-Invasive Monitoring of Traumatic Brain Injury Progression Using the Infrascanner 1 (MOBI-1) Contract $100,800.00 Clinical Trial Bellal Joseph Surgery University of Alabama at Birmingham 05/2022
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Naldemedine in Participants Undergoing Surgeries that Include a Bowel Resection or Bowel Transection Contract $586,018.76 Clinical Trial Bellal Joseph Surgery Shionogi Inc 10/2020
Investigation of the Neuromuscular Response and Training Effects of Wearable Adaptive Resistance in Children with Cerebral Palsy Fellowship $203,182.00 Research Training Benjamin Conner COM Phx Basic Medical Sci Eunice Kennedy Shriver National Institute of Child Health and Human Development 05/2021
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects with Idiopathic Pulmonary Fibrosis (IPF) Contract $433,913.00 Clinical Trial Bhupinder Natt Medicine Worldwide Clinical Trials 10/2020
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants Who Have Thrombotic Microangiopathy Associated With Contract $217,749.84 Clinical Trial Bijin Thajudeen Medicine Alexion Pharmaceuticals, Incorporated 12/2021
A Master Protocol Assessing the Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-COV-2 Monoclonal Antibodies for the Treatment of Ambulatory Patients with COVID-19 Contract $254,412.60 Clinical Trial Billie Bixby Medicine Regeneron Pharmaceuticals, Inc 10/2020
Functional Consequences of FHC Mutations in Cardiac MyBPC Grant $61,400.00 Research Brett Colson Cellular & Molecular Medicine Case Western Reserve University 11/2020
High-throughput discovery platform for modulators of cardiac muscle proteins to treat heart failure Contract $100,895.00 Research Brett Colson Cellular & Molecular Medicine Photonic Pharma, LLC. 07/2022
Skeletal Myosin-Binding Protein C Regulation and Structural Dynamics Grant $2,216,401.00 Research Brett Colson Cellular & Molecular Medicine National Institute of Arthritis and Musculoskeletal and Skin Diseases 07/2022
Project AzRORI Cooperative Agreement $69,999.00 Other Sponsored Activity Bridget Murphy Comp Pain and Addiction Ctr Arizona Alliance for Community Health Centers 09/2020
Genetic Alterations That Confer High Risk to Oral Premalignant Lesions Grant $2,412,705.00 Research Carlos Caulin Otolaryngology National Cancer Institute 07/2022
Precision Aging Network: Closing the Gap Between Cognitive Healthspan and Human Lifespan Cooperative Agreement $59,988,951.00 Research Carol Barnes Psychology National Institute on Aging 11/2021
A Phase I Randomized Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA Vaccine Against Influenza in Healthy Individuals Contract $85,313.00 Research - Industry (62.5% MTDC) Carol Gregorio Cellular & Molecular Medicine Pfizer, Incorporated 12/2021
Deciphering the Role of Lmod2 in Cardiac Muscle and In Dilated Cardiomyopathy Grant $2,211,480.00 Research Carol Gregorio Cellular & Molecular Medicine National Heart, Lung, and Blood Institute 01/2021
Arizona Biomedical Research Commission (ABRC) Educational Initiative FY 2020-2021 Contract $196,900.00 Research Training Carol Gregorio Medicine Administration Arizona Department of Health Services 02/2021

Pages